IP & Translational Development
High Coast Women’s Health Intelligence is developing an early-stage intellectual property and translational research portfolio around reproductive bleeding intelligence, inflammatory biomarker monitoring, menstrual blood profiling, and AI-supported interpretation in women’s health.
U.S. provisional patent applications have been filed covering selected early-stage platform concepts in this area.
The purpose is to move selected research questions into structured development platforms that can be tested, validated, and refined together with scientific, clinical, laboratory, technology, and investment partners.
Current provisional IP areas
Pregnancy Bleeding Intelligence
Biomarker-Guided Reproductive Inflammation Control
A research platform exploring how repeated inflammatory biomarker measurements, including CRP and related markers, may support patient-specific monitoring of reproductive inflammatory activity and future treatment-support models.
Menstrual Blood & Longitudinal Reproductive Intelligence
A research platform exploring menstrual blood as a potential pre-pregnancy biological baseline. The long-term vision is to connect menstrual blood profiles, pregnancy bleeding analysis, inflammatory biomarkers, clinical context, and outcomes into a longitudinal reproductive intelligence framework.
Development stage
These concepts are currently at the research, invention-capture, and provisional IP stage.
They are not clinical products, diagnostic tests, or treatment recommendations.
High Coast Women’s Health Intelligence is seeking scientific, clinical, laboratory, data/AI, diagnostics and investment partners for validation, development and translational research.
